Healthcare -
Biotechnology - NASDAQ - US
$ 12.73
-6.47 %
$ 1.44 B
Market Cap
-3.78
P/E
DYN - CAPITAL EXPENDITURES
Capital Expenditures DYN - Dyne Therapeutics, Inc.
-729 K
LAST VALUE
55.11%
2 YEAR CAGR
-40.32%
5 YEAR CAGR
38.74%
10 YEAR CAGR